vimarsana.com

Page 8 - ஒன்றுபட்டது உயிர் மருத்துவ இன்க் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

COVID-19: Foundation questions Medigen vaccine

The Chinese Nationalist Party (KMT)-affiliated National Policy Foundation yesterday questioned the safety and effectiveness of COVID-19 vaccine candidates from Medigen Vaccine Biologics Corp, citing a lack of phase 3 trials. Foundation deputy director Huang Hsin-hua (黃心華) made the remarks in an online news conference a day after Medigen unblinded data from its phase 2 trials. Although Medigen increased the sample pool of subjects in its phase 2 clinical tests in a bid to secure emergency use authorization, an expanded phase 2 is no substitute for phase 3 trials, Huang said. The lack of phase 3 studies sets the Taiwan-made vaccines apart from those

《TAIPEI TIMES》 Health minister Chen positive about Medigen trial data - 焦點

By Lin Chia-nan / Staff reporterPhase 2 trial data of a COVID-19 vaccine developed by Medigen Vaccine Biologics Corp (高端疫苗) looked promising, but professional review is needed to assess the vaccine’s efficacy, Minister of Health and Welfare Chen Shih-chung (陳時中) said at a news briefing at the Central Epidemic Command Center yesterday.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.